Bahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old
Bahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan to read this report and the complete Premium retrospective archive.
HealthBahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old
View Premium plansBrowse free archive reportsBahrain approves the usage of the Sinopharm BIBP COVID-19 vaccine for children between the ages of 3 and 11 years old.